Haemangioma, any site

DOID EFO MESH SNOMED PheWeb

CD2_BENIGN_HEMANGIOMA

hemangioma: A benign vascular lesion characterized by the formation of capillary-sized or cavernous vascular channels.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D18.0&

Hospital discharge: ICD-9 2280

Hospital discharge: ICD-8 22700

Cause of death: ICD-10 D18.0&

Cause of death: ICD-9 2280

Cause of death: ICD-8 22700

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

1768

CD2_BENIGN_HEMANGIOMA

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D18

Name in latin Haemangioma (quovis loco)

Similar endpoints

↥

List of similar endpoints to Haemangioma, any site based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	1700	1082	618
Unadjusted prevalence (%)	0.55	0.62	0.46
Mean age at first event (years)	47.18	44.92	51.13

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.02	1.75 [1.00, 3.06]	5.1e-2	107
15 years	0.01	1.20 [0.71, 2.03]	5.0e-1	51
5 years	0.00	2.33 [1.39, 3.91]	1.3e-3	27
1 year	0.00	6.54 [3.62, 11.82]	4.8e-10	15

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_BENIGN_HEMANGIOMA – Haemangioma, any site
GWS hits: 3

Survival analyses between endpoints

↥

Plot

before Haemangioma, any site
after Haemangioma, any site

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Haemangioma, any site

↥